Growth Metrics

Organon (OGN) Cash & Current Investments (2020 - 2026)

Organon has reported Cash & Current Investments over the past 7 years, most recently at $1.1 billion for Q1 2026.

  • For Q1 2026, Cash & Current Investments rose 104.02% year-over-year to $1.1 billion; the TTM value through Mar 2026 reached $1.1 billion, up 104.02%, while the annual FY2025 figure was $574.0 million, 18.47% down from the prior year.
  • Cash & Current Investments for Q1 2026 was $1.1 billion at Organon, up from $574.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $1.1 billion in Q1 2026 and troughed at $326.0 million in Q2 2023.
  • A 5-year average of $623.5 million and a median of $599.0 million in 2025 define the central range for Cash & Current Investments.
  • On a YoY basis, Cash & Current Investments climbed as much as 392.2% in 2022 and fell as far as 50.5% in 2022.
  • Year by year, Cash & Current Investments stood at $706.0 million in 2022, then dropped by 0.57% to $702.0 million in 2023, then grew by 0.28% to $704.0 million in 2024, then fell by 18.47% to $574.0 million in 2025, then soared by 94.43% to $1.1 billion in 2026.
  • Business Quant data shows Cash & Current Investments for OGN at $1.1 billion in Q1 2026, $574.0 million in Q4 2025, and $672.0 million in Q3 2025.